SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test
Introduction
The SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test is an advanced diagnostic tool designed to identify genetic mutations associated with early-onset epilepsy. This test is particularly important for infants who exhibit symptoms of severe neurological disorders, enabling timely intervention and management.
What the Test Measures
This genetic test detects mutations in the SCN2A gene, which are linked to early infantile epileptic encephalopathy. By analyzing the DNA through Next-Generation Sequencing (NGS) technology, we can identify specific mutations that may be causing the neurological issues.
Who Should Consider This Test
Parents should consider this test if their child shows symptoms such as:
- Frequent seizures
- Developmental delays
- Unusual movements or behaviors
- Family history of epilepsy or neurological disorders
Benefits of Taking the Test
Understanding your child’s genetic makeup can have numerous benefits, including:
- Early diagnosis and intervention
- Informed treatment options
- Better management of epilepsy symptoms
- Genetic counseling for family planning
Understanding Your Results
Results from the SCN2A Gene test will indicate whether a mutation is present. A positive result may confirm a diagnosis of early infantile epileptic encephalopathy, while a negative result can help rule out this condition. It is essential to discuss the results with a healthcare professional for proper interpretation and guidance.
Test Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Booking the Test
To book the SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test, please contact us at +2348077798758 or visit our website to schedule an appointment. Early detection can make a significant difference in your child’s health and development.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: Clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected.
For any further inquiries, feel free to reach out to our team of specialists, including neurologists and geneticists, who are dedicated to providing you with the best care and support for your child’s neurological health.
